医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
ATTO · Attovia Therapeutics, Inc.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Attovia Therapeutics, Inc.（ATTO）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 $42.1M、卖出 $2.3M；高管董事有效买入 $1.8M、有效卖出 $2.3M。最近申报 2026-08-13。
买入 Bought$42.1M
卖出 Sold$2.3M
有效买入 Effective bought$1.8M
有效卖出 Effective sold$2.3M
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-08-05 | WALSH COLIN Director | 买入 Buy · 有效 | 585,000 | $17.58 | $10.3M | SEC |
| 2026-08-05 | WALSH COLIN Director | 卖出 Sell · 有效 | 105,807 | $21.28 | $2.3M | SEC |
| 2026-08-06 | venBio Global Strategic Fund IV, L.P. 10% Owner | 买入 Buy | 382,352 | $17.00 | $6.5M | SEC |
| 2026-08-06 | Redmile Group, LLC 10% Owner | 买入 Buy | 600,000 | $17.00 | $10.2M | SEC |
| 2026-08-06 | Sanofi 10% Owner | 买入 Buy | 300,000 | $17.00 | $5.1M | SEC |
| 2026-08-06 | Frazier Life Sciences XI, L.P. 10% Owner | 买入 Buy | 588,235 | $17.00 | $10.0M | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-08-05 | GOLDMAN SACHS GROUP INC Former 10% Owner | 105,807 | $2.2M |
内部人 Insiders
WALSH COLIN、venBio Global Strategic Fund IV, L.P.、Redmile Group, LLC、Sanofi、Frazier Life Sciences XI, L.P.